326 related articles for article (PubMed ID: 10698418)
1. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
[TBL] [Abstract][Full Text] [Related]
3. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
[TBL] [Abstract][Full Text] [Related]
4. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
[TBL] [Abstract][Full Text] [Related]
6. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
11. [201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors].
Tsuda T; Kubota M; Yoshida S; Shibata M; Wakabayashi J; Obata H; Matsuyama T; Usui M; Ishii S
Kaku Igaku; 1994 Dec; 31(12):1477-94. PubMed ID: 7861647
[TBL] [Abstract][Full Text] [Related]
12. Thallium-201 chloride scintigraphy in soft tissue tumors.
Otsuka H; Terazawa K; Morita N; Otomi Y; Takao S; Iwamoto S; Osaki K; Harada M; Nishitani H
J Med Invest; 2009 Aug; 56(3-4):136-41. PubMed ID: 19763026
[TBL] [Abstract][Full Text] [Related]
13. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.
Inai R; Shinya T; Tada A; Sato S; Fujiwara T; Takeda K; Kunisada T; Yanai H; Ozaki T; Kanazawa S
Ann Nucl Med; 2015 Oct; 29(8):674-81. PubMed ID: 26036991
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
17. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors.
Caluser C; Macapinlac H; Healey J; Ghavimi F; Meyers P; Wollner N; Kalaigian J; Kostakoglu L; Abdel-Dayem HM; Yeh SD
Clin Nucl Med; 1992 Jul; 17(7):565-72. PubMed ID: 1638838
[TBL] [Abstract][Full Text] [Related]
18. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI scintigraphy in musculoskeletal tumors.
Pinkas L; Robinson D; Halperin N; Mindlin L; Cohenpour M; Baumer M; Home T
J Nucl Med; 2001 Jan; 42(1):33-7. PubMed ID: 11197977
[TBL] [Abstract][Full Text] [Related]
20. Thallium-201 scintigraphy is an effective diagnostic modality to distinguish malignant from benign soft-tissue tumors.
Kawakami N; Kunisada T; Sato S; Morimoto Y; Tanaka M; Sasaki T; Sugihara S; Yanai H; Kanazawa S; Ozaki T
Clin Nucl Med; 2011 Nov; 36(11):982-6. PubMed ID: 21975384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
